NCT00759460View on ClinicalTrials.gov

Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Schizophrenia
Interventions
DRUG

Sertindole

12 to 20 mg daily after initial up-titration, encapsulated tablets, orally, 84 days

DRUG

Olanzapine

10 to 20 mg daily after initial up-titration, encapsulated tablets, orally, 84 days

Trial Locations (1)

100083

CN002, Beijing

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00759460 - Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter